NYU Langone


 

ASCO® 2024 Insights: "KEYNOTE-942 Trial - 3-Year Update on mRNA-4157 & Pembro in Resected Melanoma"

203 views
June 12, 2024
0 Comments
Login to view comments. Click here to Login
Videos